1 – 22 of 22
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells
- 2015
- Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma.
- Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing.
- 2014
- Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics
- GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling
-
A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.
Walther, Charles LU ; Tayebwa, Johnbosco LU ; Lilljebjörn, Henrik LU
; Magnusson, Linda
LU
; Nilsson, Jenny
LU
; Vult von Steyern, Fredrik
LU
; Øra, Ingrid
LU
; Domanski, Henryk
LU
; Fioretos, Thoas
LU
and Hansén Nord, Karolin
LU
, et al.
(2014)
In Journal of Pathology
232(5).
p.534-540
Mark
- 2013
- WHO Classification of Tumours of Soft Tissue and Bone : WHO Classification of Tumours, vol. 5
- 2012
- MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma: Association With FUS Gene Rearrangement.
- Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.
- Recurrent Rearrangement of the PHF1 Gene in Ossifying Fibromyxoid Tumors.
- 2011
- Translocation t(7;19)(q22;q13)-a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?
- MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma.
- A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern.
- 2009
- Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
- 2008
-
Heterogeneous genetic profiles in soft tissue myoepitheliomas
Hansén Nord, Karolin LU ; Teixeira, Manuel R. ; Fletcher, Christopher D. M. ; Bizarro, Susana ; Staaf, Johan LU
; Domanski, Henryk
LU
; Vult von Steyern, Fredrik
LU
; Panagopoulos, Ioannis
LU
; Mandahl, Nils
LU
and Mertens, Fredrik
LU
(2008)
In Modern Pathology
21(11).
p.1311-1319
Mark
- 2005
- Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene
- 2004
- The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
- Activation of the GLI Oncogene through Fusion with the beta-Actin Gene (ACTB) in a Group of Distinctive Pericytic Neoplasms: Pericytoma with t(7;12).
- 2002
- World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
- Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
- Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.
- 2001
- Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification